Seer Investor Relations Material
Latest events
Q1 2025
Seer
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Seer Inc
Access all reports
Seer Inc develops life sciences technologies intended to enable discovery of proteomic biomarkers with high throughput and precision. The company’s products support research in areas such as biomarker identification, disease detection, and therapeutic development. Seer serves pharmaceutical, academic, and research institutions in the life sciences sector. The company is headquartered in Redwood City, California, and its shares are listed on the NASDAQ.
Key slides for Seer Inc
43rd Annual J.P. Morgan Healthcare Conference 2025
Seer Inc
43rd Annual J.P. Morgan Healthcare Conference 2025
Seer Inc
Latest articles
)
Airbnb: The Hospitality Giant Without Property
Airbnb has grown from an idea to help the Co-Founders make rent, to one of the most dominant companies in the global hospitality industry.
13 Jun 2025
)
MSCI: Indexing the World
The story of how MSCI has become the backbone of global finance through its indexes, powering decision-making across trillions in assets.
30 May 2025
)
A Purpose-Built AI Chat for Finance and IR Professionals
Quartr Pro's new AI chat lets IR and finance professionals ask anything across 13,000+ public companies and get instant answers.
27 May 2025
Ticker symbol
SEER
Country
🇺🇸 United States